In the SURMOUNT clinical trials, participants using the highest dose (15 mg) achieved an average weight loss of approximately 1520% of their initial body weight over 72 weeks when combined with intensive lifestyle support
While results vary, most users start noticing changes within the first few weeks, with gradual, steady weight loss over time
We also compared how many patients needed to start using new drugs to meet their treatment goals and the odds that a patient would need to start using new drugs
2022;7:eabn3127
Wong HC, Cheung BC, Yuen VW, Teoh JY, Chiu PK, Ng CF
Why GLP-1 success in the real world looks different than in trials In the evolving landscape of GLP-1 trends, Ozempic (semaglutide) has garnered attention for its weight loss effects